AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 173 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $45,000 | -79.4% | 1,281 | -68.6% | 0.00% | -83.3% |
| Q2 2020 | $218,000 | +2322.2% | 4,085 | +2817.9% | 0.01% | +1100.0% |
| Q1 2019 | $9,000 | -98.3% | 140 | -97.9% | 0.00% | -96.7% |
| Q3 2018 | $517,000 | +15.7% | 6,701 | +26.4% | 0.03% | +7.1% |
| Q2 2018 | $447,000 | +3625.0% | 5,301 | +3457.7% | 0.03% | +2700.0% |
| Q1 2018 | $12,000 | -95.7% | 149 | -96.5% | 0.00% | -96.0% |
| Q3 2017 | $281,000 | +57.0% | 4,215 | +21.3% | 0.02% | +47.1% |
| Q2 2017 | $179,000 | -47.0% | 3,476 | +15.4% | 0.02% | -66.0% |
| Q4 2014 | $338,000 | – | 3,013 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |